Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

158.78
-1.3400-0.84%
Post-market: 158.07-0.7129-0.45%17:49 EDT
Volume:3.49M
Turnover:552.74M
Market Cap:246.27B
PE:23.77
High:160.05
Open:159.80
Low:156.72
Close:160.12
52wk High:212.71
52wk Low:153.41
Shares:1.55B
Float Shares:1.50B
Volume Ratio:1.32
T/O Rate:0.23%
Dividend:3.17
Dividend Rate:2.00%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.21%
PB:4.90
PE(LYR):24.28

Loading ...

AstraZeneca Falls Tuesday, Underperforms Market

Dow Jones
·
Sep 09

Top Midday Stories: GE Aerospace to Acquire Consolidated Precision Products; Qualcomm Issues Share Warrant to Amazon

MT Newswires Live
·
Sep 08

Dow Jones Top Company Headlines at 11 am ET: GE Aerospace to Buy Consolidated Precision Products | GameStop ...

Dow Jones
·
Sep 08

Amgen Says Phase 3 Study Meets Primary Endpoint in Small Cell Lung Cancer

MT Newswires Live
·
Sep 08

AstraZeneca Says Lung-Disease Drug Shows Benefits Across Patient Groups

Dow Jones
·
Sep 08

AstraZeneca Says Tozorakimab Cuts COPD Exacerbations in Phase 3 Trials

MT Newswires Live
·
Sep 08

Guardant Health's Breast Cancer Diagnostic Approved by US FDA

MT Newswires Live
·
Sep 08

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 08

AstraZeneca's Etcamah Opens New Breast-Cancer Treatment Paradigm

Dow Jones
·
Sep 07

J.P. Morgan Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 07

Jefferies Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 07

AstraZeneca Scores Minor Positive with U.S. Approval for Breast-Cancer Drug

Dow Jones
·
Sep 07

Citi Keeps Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Sep 07

AstraZeneca Gets FDA Approval for Breast Cancer Treatment

Dow Jones
·
Sep 05

AstraZeneca PLC Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 05

Alnylam's Zilebesiran Sees Commercial Opportunity From Baxfendy Launch, Oppenheimer Says

MT Newswires Live
·
Sep 04

AstraZeneca's New Lung Treatment Could Become Market Leader

Dow Jones
·
Sep 03

Berenberg Bank Reaffirms Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Sep 03

AstraZeneca PLC Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 03

Deutsche Bank Sticks to Its Sell Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 02